Morphological imaging in the localization of neuroendocrine gastroenteropancreatic tumors found by somatostatin receptor scintigraphy

被引:6
|
作者
Saga, T
Shimatsu, A
Koizumi, K
Ichikawa, T
Yamamoto, K
Noguchi, S
Doi, R
Ishibashi, M
Machinami, R
Nakamura, K
Sakahara, H
Endo, K
机构
[1] Kyoto Univ, Grad Sch Med, Dept Nucl Med, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Kyoto 6068507, Japan
[3] Kyoto Natl Hosp, Clin Res Inst, Kyoto, Japan
[4] Tokyo Med Univ, Hachioji Med Ctr, Dept Radiol, Hachioji, Tokyo, Japan
[5] Tama Hosp, Nippon Med Sch, Dept Radiol, Tamanagayama, Japan
[6] Wakasa Wan Energy Res Ctr, Div Med, Tsuruga, Japan
[7] Osaka Univ, Sch Med, Dept Surg Oncol, Suita, Osaka 565, Japan
[8] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Internal Med 4, Kawasaki, Kanagawa, Japan
[9] Kawakita Gen Hosp, Dept Pathol, Tokyo, Japan
[10] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan
[11] Hamamatsu Univ Sch Med, Dept Radiol, Hamamatsu, Shizuoka 43131, Japan
[12] Gunma Univ, Sch Med, Dept Nucl Med, Maebashi, Gumma 371, Japan
关键词
somatostatin receptor scintigraphy; morphological imaging; functional imaging; neuroendocrine gastroenteropancreatic tumor;
D O I
10.1080/02841850510021003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the necessity of morphological images ( MI) in reading somatostatin receptor scintigraphy ( SRS) in patients with suspected neuroendocrine gastroenteropancreatic ( GEP) tumors. Material and Methods: A Japanese multicenter clinical trial of SRS was conducted in 40 patients with suspected GEP tumors. Three experienced radiologists interpreted the images in three separate sessions in a blinded manner ( 1: SRS images alone, 2: MI alone, 3: SRS and MI analyzed simultaneously), and the reading results of each session were compared. In addition, the diagnostic abilities of SRS, MI and SRS alone and simultaneous SRS and MI readings were compared for patients where final diagnosis was obtained. Results: SRS detected more suspected lesions ( positive or inconclusive uptake) than morphological images did ( 51 vs 27 lesions), but included many physiological uptakes detected as positive or inconclusive uptakes. Combined reading of SRS and morphological images helped to correctly recognize these physiological uptakes, and also helped in determining the anatomical localization of the abnormal uptakes. Combined reading of SRS and morphological images gave the highest diagnostic impact. Conclusion: The sensitivity of SRS with regard to GEP is high. However the specificity is very low. Morphologic imaging is necessary for the exclusion of physiological uptake and correct anatomic location of an abnormal tracer uptake. The combined reading of SRS and morphologic imaging studies gives the highest diagnostic impact.
引用
下载
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [41] Incremental Diagnostic Value and Impact on Patient Management of Somatostatin Receptor Scintigraphy with Indium-111-Pentetreotide in Gastroenteropancreatic Neuroendocrine Tumors
    Usmani, Sharjeel
    Khan, Haider Ali
    Abdulla, Maha
    Ahmed, Najeeb
    abu Huda, Fawaz
    Marafi, Fahad
    al Kandari, Farida
    al Mohannadi, Shihab
    al Nafisi, Naheel
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (04) : 356 - 361
  • [42] Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
    Lebtahi, R
    Cadiot, G
    Delahaye, N
    Genin, R
    Daou, D
    Peker, MC
    Chosidow, D
    Faraggi, M
    Mignon, M
    Le Guludec, D
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1602 - 1608
  • [43] Functional Imaging of Neuroendocrine Tumors - A Head to Head Comparison of Somatostatin Receptor Scintigraphy, MIBG Scintigraphy and FDG-PET
    Binderup, T.
    Pfeifer, A.
    Loft, A.
    Mortensen, J.
    Palnaes-Hansen, C.
    Knigge, U.
    Kjaer, A.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 99 - 100
  • [44] Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization
    Jensen, RT
    Gibril, F
    Termanini, B
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1997, 70 (5-6): : 481 - 500
  • [45] Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors
    Frilling, A
    Malago, M
    Martin, H
    Broelsch, CE
    SURGERY, 1998, 124 (06) : 1000 - 1004
  • [46] Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck
    Kau, R
    Arnold, W
    ACTA OTO-LARYNGOLOGICA, 1996, 116 (02) : 345 - 349
  • [47] Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors - Discussion
    McHenry, CR
    Meko
    Grant, C
    Frilling, A
    Proye, C
    Thompson, NW
    SURGERY, 1996, 120 (06) : 983 - 984
  • [48] Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors
    Janson, ET
    Kälkner, KM
    Eriksson, B
    Westlin, JE
    Öberg, K
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (08) : 877 - 882
  • [49] Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).
    Spanu, A
    Schillaci, O
    Falchi, A
    Marongiu, P
    Pisu, N
    Madeddu, G
    Solinas, ME
    Solinas, P
    Scopinaro, F
    Madeddu, G
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 299P - 299P
  • [50] Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
    Jonathan Strosberg
    Larry Kvols
    World Journal of Gastroenterology, 2010, 16 (24) : 2963 - 2970